Results 1 to 10 of about 434,252 (248)

Treatment of dengue fever

open access: yesInfection and Drug Resistance, 2012
Senaka Rajapakse,1,2 Chaturaka Rodrigo,1 Anoja Rajapakse31Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Sri Lanka; 2Lincoln County Hospital, United Lincolnshire NHS Trust, Lincoln, UK; 3Kings Mill Hospital, Sherwood Forest ...
Rajapakse S, Rodrigo C, Rajapakse A
doaj   +7 more sources

A model of dengue fever [PDF]

open access: yesBioMedical Engineering OnLine, 2003
El dengue es una enfermedad que ahora es endémica en más de 100 países de África, América, Asia y el Pacífico Occidental. Se transmite al hombre por mosquitos (Aedes) y existe en dos formas: fiebre del dengue y fiebre hemorrágica del dengue. La enfermedad puede ser contraída por uno de los cuatro virus diferentes.
Mohammed Derouich   +2 more
openaire   +7 more sources

Dengue and Dengue Hemorrhagic Fever [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2015
Dengue is endemic in at least 100 countries in Asia, the Pacific, the Americas, Africa, and the Caribbean. The World Health Organization (WHO) estimates that 50 to 100 million infections occur yearly, including 500,000 dengue hemorrhagic fever (DHF ...
Maysaa Saeed, Tarek Attia
doaj   +2 more sources

Dengue and Dengue Hemorrhagic Fever [PDF]

open access: yesClinical Microbiology Reviews, 1997
SUMMARY Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic ...
E B, Hayes, D J, Gubler
openaire   +5 more sources

Development of a Singleplex Real-Time Reverse Transcriptase PCR Assay for Pan-Dengue Virus Detection and Quantification

open access: yesViruses, 2022
Dengue virus (DENV) infection is a significant global health problem. There are no specific therapeutics or widely available vaccines. Early diagnosis is critical for patient management.
Adisak Songjaeng   +12 more
doaj   +1 more source

Impaired Fibrinolysis in the Pathogenesis of Dengue Hemorrhagic Fever [PDF]

open access: yes, 2002
The mechanisms contributing to bleeding complications in dengue hemorrhagic fever were studied by investigating the pattern of activation of the coagulation and fibrinolytic systems in 50 children with severe dengue hemorrhagic fever.
Eric C.M. van Gorp   +30 more
core   +2 more sources

Dengue virus NS1 secretion is regulated via importin-subunit β1 controlling expression of the chaperone GRp78 and targeted by the clinical drug ivermectin

open access: yesmBio, 2023
Dengue virus (DENV) is a major human pathogen. An important pathogenicity factor is non-structural protein 1 (NS1) required for viral replication and secreted from infected cells.
Solène Denolly   +12 more
doaj   +1 more source

Synergistic anti-SARS-CoV-2 activity of repurposed anti-parasitic drug combinations

open access: yesBMC Pharmacology and Toxicology, 2022
Background COVID-19 pandemic has claimed millions of lives and devastated the health service system, livelihood, and economy in many countries worldwide.
Kunlakanya Jitobaom   +7 more
doaj   +1 more source

Facial nerve palsy: An atypical presentation of dengue fever

open access: yesAsian Journal of Medical Sciences, 2023
Dengue fever is a grave public health concern in tropical countries. The disease spectrum of dengue fever is multi-systemic, although neurologic complications of dengue fever is relatively uncommon. The pathogenesis of neurologic manifestations in dengue
Rishav Mukherjee , Debarup Das
doaj   +1 more source

Genetic Variation in the Domain II, 3′ Untranslated Region of Human and Mosquito Derived Dengue Virus Strains in Sri Lanka

open access: yesViruses, 2021
Genetic variations in dengue virus (DENV) play a distinct role in epidemic emergence. The DENV 3′ UTR has become a recent interest in research. The objective of the study was to examine the genetic variation in the domain II, 3′ UTR region of human and ...
P. D. Dayananda   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy